Bio-business in brief: The case of Cytokinetics Inc.

One of the best ways to build a discovery biopharma company is to have a unique class of molecular targets, a good patent portfolio, venture capital to power growth, experienced and wise advisors and, in due course, strategic collaborations with big pharma companies. The more these conditions are met, the more likely the success of the venture. The company Cytokinetics - built around its academic expertise in the area of the cytoskeleton and motor proteins - fulfilled all these criteria and serves as a good case study for future entrepreneurs of this sort.